Suven Pharmaceuticals informs about disclosure

19 Jun 2024 Evaluate

Suven Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSCGlobal Capital Markets Singapore.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

543.55 -5.55 (-1.01%)
05-Dec-2025 15:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.50
Dr. Reddys Lab 1274.50
Cipla 1520.00
Zydus Lifesciences 930.75
Lupin 2098.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×